Loading...
XLONCVSG
Market cap743mUSD
Dec 24, Last price  
826.00GBP
1D
0.73%
1Q
-26.25%
Jan 2017
-25.11%
IPO
253.75%
Name

CVS Group PLC

Chart & Performance

D1W1MN
XLON:CVSG chart
P/E
9,557.62
P/S
91.55
EPS
0.09
Div Yield, %
0.01%
Shrs. gr., 5y
0.30%
Rev. gr., 5y
9.75%
Revenues
647m
+6.41%
38,972,00062,150,00076,605,00085,527,000101,491,000108,745,000120,100,000142,900,000167,300,000218,100,000271,800,000327,300,000406,500,000427,800,000510,100,000554,200,000608,300,000647,300,000
Net income
6m
-85.20%
346,000-339,0003,038,0003,058,0003,487,0002,888,0004,000,0004,800,0006,800,0007,000,00011,500,00010,700,0008,200,0005,700,00019,300,00025,700,00041,900,0006,200,000
CFO
68m
-19.76%
5,282,0002,991,0008,894,0008,767,00014,532,00010,709,00013,400,00017,000,00018,600,00027,900,00029,700,00037,400,00041,400,00077,600,00060,200,00075,500,00084,500,00067,800,000
Dividend
Oct 31, 20248 GBP/sh
Earnings
Feb 26, 2025

Profile

CVS Group plc engages in veterinary, pet crematoria, online pharmacy, and retail businesses. The company operates through four segments: Veterinary Practices, Laboratories, Crematoria, and Online Retail. It operates animal veterinary practices and complementary veterinary diagnostic businesses. The company also provides pet cremation and clinical waste services for veterinary practices. In addition, it operates Animed Direct, an online pharmacy and retail business that sells prescription and non-prescription medicines, premium pet foods, and other pet care products; and an online dispensary. Further, the company provides burial grounds; and veterinary instrumentation supply and referral services. It owns 506 veterinary practices, 3 laboratories, 7 crematoria, and an online pharmacy. CVS Group plc was founded in 1999 and is based in Diss, the United Kingdom.
URL
https://www.cvsukltd.co.uk/
IPO date
Oct 10, 2007
Employees
8,500
Domiciled in
GB
Incorporated in
GB

Valuation

Title
GBP in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑062023‑062022‑062021‑062020‑062019‑062018‑062017‑062016‑062015‑06
Income
Revenues
647,300
6.41%
608,300
9.76%
554,200
8.65%
Cost of revenue
596,500
546,000
511,400
Unusual Expense (Income)
NOPBT
50,800
62,300
42,800
NOPBT Margin
7.85%
10.24%
7.72%
Operating Taxes
11,800
12,000
10,300
Tax Rate
23.23%
19.26%
24.07%
NOPAT
39,000
50,300
32,500
Net income
6,200
-85.20%
41,900
63.04%
25,700
33.16%
Dividends
(5,400)
(5,000)
(4,600)
Dividend yield
0.75%
0.35%
0.39%
Proceeds from repurchase of equity
1,500
900
2,300
BB yield
-0.21%
-0.06%
-0.19%
Debt
Debt current
13,900
13,300
9,400
Long-term debt
380,400
292,700
283,900
Deferred revenue
(503,500)
Other long-term liabilities
(400)
503,500
Net debt
376,900
284,500
241,900
Cash flow
Cash from operating activities
67,800
84,500
75,500
CAPEX
(39,500)
(45,700)
(24,500)
Cash from investing activities
(140,500)
(99,900)
(45,100)
Cash from financing activities
68,300
(12,100)
(15,100)
FCF
(78,200)
46,300
4,100
Balance
Cash
16,500
21,500
49,000
Long term investments
900
2,400
Excess cash
23,690
Stockholders' equity
212,900
211,000
173,400
Invested Capital
548,300
433,900
379,210
ROIC
7.94%
12.37%
8.71%
ROCE
8.67%
13.58%
10.12%
EV
Common stock shares outstanding
71,657
71,652
71,553
Price
10.08
-49.07%
19.79
19.50%
16.56
-31.43%
Market cap
722,300
-49.06%
1,418,001
19.67%
1,184,910
-31.06%
EV
1,099,300
1,702,501
1,426,810
EBITDA
109,300
112,700
90,400
EV/EBITDA
10.06
15.11
15.78
Interest
12,600
7,400
6,800
Interest/NOPBT
24.80%
11.88%
15.89%